Sarepta Therapeutics To Join S&P Midcap 400, Effective June 3
Sarepta Therapeutics To Join S&P Midcap 400, Effective June 3
Sarepta Therapeutics將加入標普中型股400指數,自6月3日起生效
Sarepta Therapeutics will replace Shockwave Medical in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson is acquiring Shockwave Medical in a deal expected to be completed soon pending final closing conditions.
Sarepta Therapeutics將在標準普爾中型股400指數中取代Shockwave Medical,該指數將在6月3日星期一開盤前生效。標普500指數成份股公司強生正在收購Shockwave Medical,該交易預計將很快完成,等待最終成交條件。